{"id":"W3097746180","doi":"10.1182/blood-2020-136607","title":"Investigational CD47-Blocker TTI-622 Shows Single-Agent Activity in Patients with Advanced Relapsed or Refractory Lymphoma: Update from the Ongoing First-in-Human Dose Escalation Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"CD47; Medicine; Pharmacodynamics; Tolerability; Pharmacology; Adverse effect; Internal medicine; Refractory (planetary science); Lymphoma; Pharmacokinetics; Immune system; Immunology; Oncology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001598424,0.0002071495,0.0002809579,0.00006092104,0.0002155761,0.00002514185,0.0001813026,0.000134089,0.0001130573],"category_scores_gemma":[0.0001264728,0.0001440274,0.00004084857,0.0002527421,0.00008511439,0.0003125322,0.00009327591,0.0002256887,0.00002855915],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001097747,"about_ca_system_score_gemma":0.00006995176,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001466258,"about_ca_topic_score_gemma":0.0009407265,"domain_scores_codex":[0.9985498,0.0003362999,0.0003635293,0.0004086629,0.0001038367,0.0002378643],"domain_scores_gemma":[0.9992339,0.0001827612,0.0002325278,0.0002732466,0.00004966441,0.00002789555],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00157222,0.005641285,0.8688568,0.000009492862,0.0001935511,0.000006228921,0.003335307,0.0001805308,0.114443,0.00001349945,0.00009125184,0.005656781],"study_design_scores_gemma":[0.01759531,0.0009680977,0.9632742,0.00007518268,0.00006890246,6.637281e-7,0.0002042169,0.00003980007,0.01703431,0.0000202374,0.0005269039,0.000192152],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984036,0.0002227037,0.00001259026,0.0003766473,0.0001161835,0.0007684216,0.00003188733,0.00004112831,0.00002683337],"genre_scores_gemma":[0.9992699,0.000005826429,0.00007212257,0.0001854614,0.00002890954,0.00005497889,0.0003338831,0.00002226446,0.00002665983],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09740871,"threshold_uncertainty_score":0.5873268,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01970412747875858,"score_gpt":0.2233169555120087,"score_spread":0.2036128280332501,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}